2018
DOI: 10.1074/jbc.ra117.000127
|View full text |Cite
|
Sign up to set email alerts
|

Rhesus monkey TRIM5α protein SPRY domain contributes to AP-1 activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 71 publications
1
2
0
Order By: Relevance
“…the NF-κB reporter under basal conditions, which is consistent with previous studies from us and others 38,39,46 , these proteins negatively regulated TNFα-mediated NF-κB activation, as seen with huTRIM5α (Fig. 9e).…”
Section: Conserved Suppression Effects Of Nonhuman Trim5α and Trimcyp...supporting
confidence: 92%
“…the NF-κB reporter under basal conditions, which is consistent with previous studies from us and others 38,39,46 , these proteins negatively regulated TNFα-mediated NF-κB activation, as seen with huTRIM5α (Fig. 9e).…”
Section: Conserved Suppression Effects Of Nonhuman Trim5α and Trimcyp...supporting
confidence: 92%
“…2b ). This AP-1 activation by SPSB1 may be explained in part by a recent finding that the SPRY domain of RhTRIM5α is essential for AP-1 but not NF-κB activation 25 . In addition, because ubiquitination of heterogeneous nuclear ribonucleoprotein A1 (HnRNP A1) by SPSB1 induces the expression of Rac1B 26 , which in turn elevates mRNA expression of c-Jun N-terminal kinase 2 and c-JUN 27 , it is plausible that these events cooperate to achieve activation of AP-1-dependent transcription.…”
Section: Discussionmentioning
confidence: 97%
“…The RING domain-associated ubiquitin ligase activity is instrumental in the restriction mechanism, as it directs some viral components as well as TRIM5α itself to proteasomal degradation [ 20 , 21 ]. The RING domain also promotes the formation of K63-linked ubiquitin chains that play a role in the restriction process [ 22 , 23 ] and activate innate immune pathways mediated by NF-κB, AP-1 and IFN-I [ 24 , 25 , 26 , 27 ]. At its C-terminus, TRIM5α has a SPRY/B30.2 domain whose sequence determines retroviral target specificity, i.e., which viruses are inhibited [ 28 , 29 ].…”
Section: Introductionmentioning
confidence: 99%